Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Mallinckrodt
Baxter
Julphar
UBS
Healthtrust
Argus Health
Dow

Generated: April 24, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Accord Hlthcare Inc

« Back to Dashboard

Accord Hlthcare Inc Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Accord Hlthcare Inc cabazitaxel 207949 20MG/ML(60MG/3ML) INJECTABLE;INJECTION
Accord Hlthcare Inc lurasidone hydrochloride 208049 20MG TABLET;ORAL
Accord Hlthcare Inc pemetrexed disodium 203485 100MG INJECTABLE;INJECTION
Accord Hlthcare Inc lacosamide 205011 200MG TABLET;ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Colorcon
Accenture
AstraZeneca
US Army
Chinese Patent Office
McKesson
Farmers Insurance
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.